2015年度8月召開北京首屆前列腺癌研討會醫(yī)學(xué)會議公告
會議日期：2015.08.08-2015.08.09
會議地點(diǎn)：北京
聯(lián)系人：鄂女士（jane)
聯(lián)系電話：024-31930319
E-mail：jane@pcsconference.com
傳真：024-86085759
聯(lián)系地址：遼寧省沈陽市皇姑區(qū)長江街134號
學(xué)分：I類2分
世紀(jì)科學(xué)國際癌癥大會——2015首屆前列腺癌研討會將于2015年8月8 - 9日在中國北京舉行。
大會旨在為前列腺癌研究提供一個從基礎(chǔ)科學(xué)到臨床應(yīng)用的專屬平臺，促進(jìn)國際交流，加強(qiáng)對外合作。本次大會設(shè)置了12個專題論壇，其中包括前列腺癌基礎(chǔ)科學(xué)前沿進(jìn)展、早期診斷、臨床管理、手術(shù)治療等領(lǐng)域。
目前已有來自近20個國家50余名代表確定參會和參加演講，我們真誠的邀請您參加本次大會，大會還有報告機(jī)會和海報展示交流。演講報名及論文摘要收錄截止期臨近，我們真誠地希望您能蒞臨參加并積極參與相關(guān)交流活動m.gydjdsj.org.cn。
關(guān)于前列腺癌研討會日程，請參見：
PCS Global Cancer Conference
1st International Prostate Cancer Symposium – 2015
Theme: World Dreams of Early Diagnosis and Early Therapy of Prostate Cancer
1st International Lung Cancer Symposium – 2015
Theme: Advanced Early Diagnosis and Early Therapy of Lung Cancer
August 8-9, 2015 Place: Beijing, China
| Registration Day Day 0: Time: 8:30-22:00 (Whole day) Aug. 7, 2015 (Friday) Registration Place: Lobby of Conference Hotel | |
| Opening Ceremony Keynote Forum and Plenary Day 1: Time: 8:40-12:25 (Morning), Aug. 8, 2015 (Saturday) Conference Room: 2-1 | |
| 8:40-8:55 | Group Photo for All Delegates and Speakers |
| 9:00-9:15 | Opening Ceremony |
| 09:15-09:25 | Chair: Dr. Chiming Wei, Professor and Chief Scientist, Chongqing Academy of Science and Technology, China; President, American Nanomedicine Institute, USA Co-chair: Dr. Edwin Cheung, Professor, Faculty of Health Sciences, University of Macau, Macau SAR, China |
| 09:25-09:55 | Title: Clinical Implication of Molecular Profiling in Lung Cancer Dr. Zhaolin Xu, Professor, Department of Pathology, Dalhousie University, Canada |
| 09:55-10:25 | Title: Prostate Cancer Region Prediction using Hybrid Molecular and Optical Imaging for Targeted Bomarker Aalysis Dr. Frederic (Rick) D. McKenzie, Professor and Chair, Modeling, Simulation, & Visualization Engineering Dept. Joint Appointment, Electrical & Computer Engineering Dept, Old Dominion University, USA |
| 10:25-10:55 | Title: Functional Characterization and Molecular Mechanism of a FABP5-PPARγ-VEGF Signaling Axis Promoting Tumorigenicity in Prostatic Cancer Dr. Youqiang Ke, Professor & Director of Molecular Pathology, Dept. of Molecular & Clinical Cancer Medicine, The University of Liverpool, UK |
| 10:55-11:25 | Title: Genomic Analysis of Androgen Signaling in Prostate Cancer Cells Dr. Edwin Cheung, Professor, Faculty of Health Sciences, University of Macau, Macau SAR, China |
| 11:25-11:55 | Title: Genetic Markers for Prostate Cancer (PCa) in African Male Dr. Shingai Mutambirwa, Professor and Head of Department of Urology, Sefako Makgatho Health Sciences University, South Africa |
| 11:55-12:25 | Title: Circulating Tumor Cells in the Diagnosis and Monitoring of Breast Cancer Dr. Beiyun Chen, Associate Professor, Department of Pathology, Mayo Clinic, Rochester, MN, USA |
| 12:30-13:30 |
Lunch |
| Track 1: Basic Research and Clinical Diagnosis of Cancers Day 1: Time: 13:30-18:30 (Afternoon), Aug. 8, 2015 Conference Room: 2-1 | |
| 13:30-13:40 | Session Introduction Session Chair: Dr. Xiang-Dong Wang, Director and Senior Scientist, Nutrition and Cancer Biology Laboratory, Professor, Tufts University, USA Session Co-chair: Dr. Andrew A. Goldenberg, Professor Emeritus, Mechanical Engineering, Consulting Engineer, Electrical and Computer Engineering, University of Toronto, Canada |
| 13:40-14:05 | Title: Carotenoid Chemoprevention of Lung Cancer: What Lessons We Learned Dr. Xiang-Dong Wang, Director and Senior Scientist, Nutrition and Cancer Biology Laboratory, Professor, Tufts University, USA |
| 14:05-14:30 | Title: Bioengineering Three-dimensional Culture Model of Human Lung Cancer Cells for Screening EGFR Targeted Inhibitors Dr. Xiuli Wang, Professor, Hisitology and Embryology Department, Dalian Medical Univeristy, China |
| 14:30-14:55 | Title: FoxQ1 Overexpression Influences Poor Prognosis in NSCLC, Through Regulating EMT and Increasing Chemosensitivity Dr. Jianfei Huang, Deputy Director, Department of Pathology, Nantong University Affiliated Hospital, Nantong, Jiangsu, China |
| 14:55-15:20 | Title: Chemoprevention of Prostate Cancer by Kava Product Dr. Yaxiong Tang, Professor, Chengdu Institute of Biology, Chinese Academy of Sciences, China |
| 15:20-15:45 | Title: MRI-Guided Robot-Assisted Prostate Surgery Dr. Andrew A. Goldenberg, Professor Emeritus, Mechanical Engineering, Consulting Engineer, Electrical and Computer Engineering, University of Toronto, Canada |
| 15:45-16:00 | Coffee Break |
| 16:00-16:25 | Title: Anesthesia for Robotic Prostatectomy: Challenges, Management, and Safe Clinical Discharge Criteria from the Operating Room Dr. Menekse Oksar, Assistant Professor, Department of Anesthesiology and Reanimation, Mustafa Kemal University, Turkey |
| 16:25-16:50 | Title: Microvesicles in Cancer Pogression and Dagnosis Dr. Khalid Al-Nedawi, Assistant Professor, Department of Medicine, McMaster University and St. Joseph’s Healthcare, Canada |
| 16:50-17:15 | Title: Unraveling the Crosstalk between Circadian Rhythm, Metabolism and Autophagy in Determinming Prostate Cancer Cell Viability Dr. Benedetto Grimaldi, Team Leader, Drug Discovery and Development, Italian institute of technology, Italy |
| 17:15-17:40 | Title: AKR1C3 Overexpression may serve as a Promising Biomarker for Prostate Cancer Progression and Therapy Target Dr. Yuantong Tian, College of Basic Medical Sciences, Jilin University, China |
| 17:40-18:05 | Title: Identification of Specific DNA Methylation Sites on the Y Chromosome as Biomarker in Prostate Cancer Dr. Ying li Sun, Professor, Beijing Institute of Genomics, Chinese Academy of Sciences, China |
| 18:05-18:30 | Title: A Novel Tumor Metastasis Suppressor Gene LASS2/TMSG1 Interacts with Vacuolar ATPase through its Homeodomain Dr. Fei Pei, Clinical and Research Associate Professor, Department of Pathology, Health Science Center, Peking University, China |
| 19:00 | Welcome Banquet |
| Trake2: Advanced Research on Prostate Cancer and Lung Cancer Day 2: Time: 09:00-11:30 (Morning), Aug. 9, 2015 Conference Room: 2-1 | |
| 09:00-09:10 | Session Introduction Session Chair: Dr. John Mao, Senior Vice President and Head of Development, Foresee Pharmaceuticals, USA Session Co-chair: Dr. Yun Zhang, Assistant Research Scientist, Department of Urology, Institute for Health Innovation and Policy, University of Michigan, USA |
| 09:10-09:35 | Title: Rapid Development and Commercialization of a Proprietary Sustained-release Depot Formulation of Leuprolide for the Treatment of Advanced Prostate Cancer Dr. John Mao, Senior Vice President and Head of Development, Foresee Pharmaceuticals, USA |
| 09:35-10:00 | Title: Integrative Genetic and Epigenetic Analyses Identify Driver Long Noncoding RNAs in Prostate Cancer Dr. Housheng Hansen He, Assistant Professor, Department of Medical Biophysics, University of Toronto; Scientist, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada |
| 10:00-10:25 | Title: The Impact of Regionalization of MIRP on Outcome in the US Dr. Yun Zhang, Assistant Research Scientist, Department of Urology, Institute for Health Innovation and Policy, University of Michigan, USA |
| 10:25-10:40 | Coffee Break |
| 10:40-11:05 | Title: Correlation of EGFR Expression, Gene Copy Number and Clinicopathological Status in NSCLC Dr. Rania Gaber, Department of Pathology, Faculty of Medicine, University of Alexandria, Egypt |
| 11:05-11:30 | Title: An Expression Signature at Quantec Analysis of Radiation-Induced Toxicity in Patients Receiving Stereotactic Body Radiotherapy(SBRT) for Lung Tumors Dr. Bixiu Wen, Chairman and Professor, Department of Radiation Oncology, The First Affiliated Hospital Sun Yat-sen University, Guangzhou, China |
| 12:30-13:30 | Lunch |
| Track 3: Prostate Cancer and Related Research Day 2: Time: 13:30-16:50 (Afternoon), Aug. 9, 2015 Conference Room: 2-1 | |
| 13:30-13:40 | Session Introduction Session Chair: Dr. Finn Edler von Eyben, Center of Tobacco Control Research, Denmark Session Co-chair:Dr. Chiming Wei, Professor and Chief Scientist, Chongqing Academy of Science and Technology, China; President, American Nanomedicine Institute, USA |
| 13:40-14:05 | Title: Advanced Nanomedicine in Cancer Diagnosis and Treatment Dr. Chiming Wei, Professor and Chief Scientist, Chongqing Academy of Science and Technology, China; President, American Nanomedicine Institute, USA |
| 14:05-14:30 | Title: New Trends in Radiotherapy for Prostate Cancer Dr. Finn Edler von Eyben, Center of Tobacco Control Research, Denmark |
| 14:30-14:55 | Title: Behavioral Stress, Apoptosis Network and Personalized Therapy for Advanced Prostate Cancer Dr. George Kulik, PhD Associate Professor of Cancer Biology; Department of Life Sciences, Chair, College of Science & General Studies; Alfaisal University, KSA, Department of Cancer Biology, Wake Forest University Health Sciences, USA |
| 14:55-15:20 | Title: Salvage Brachytherapy in Prostate Cancer after Failure from Radiation Treatment Dr. Ivan Henriquez, Radiation Oncology, Medical Staff, University Hospital Sant Joan, Spain |
| 15:20-15:35 | Coffee Break |
| 15:35-16:00 | Title: Utility of Immunohistochemical Staining of P63 and Amacr in Prostate Neoplasm: A Cross Sectional Stufy. Dr. Ankush Nayyar, Third year resident, Department of pathology, IMS And SUM Hospital, Bhubaneswar, India |
| 16:00-16:25 | Title: High Intensity Focused Ultrasound for Prostate Cancer Treatment - status Quo 2015 Dr. Vyacheslav Solovov, Professor, Head of the Interventional Oncology Department, Samara Oncology Center, Russia |
| 16:25-16:50 | Title: Cost-effectiveness Analysis of Treatments for Low Risk and Intermediate Risk Localised Prostate Cancer Dr. Chunhuan Lao, PhD Candidate in Health Economics, Waikato Clinical Campus, The University of Auckland, New Zealand |
更多醫(yī)學(xué)會議資訊相關(guān)推薦：
2015年度醫(yī)學(xué)會議暨北京第十二屆天壇全國呼吸內(nèi)鏡介入技術(shù)學(xué)習(xí)班
